Emergent Biosolutions, Inc. (EBS) Social Stream
EMERGENT BIOSOLUTIONS INC (EBS) Price Targets From Analysts
Use the tables below to see what analysts covering EMERGENT BIOSOLUTIONS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 7 | $120 | $50 | $83.666 | $2.08 | 3922.4% |
| 2021-11-10 | 7 | $120 | $50 | $80 | $2.08 | 3746.15% |
| 2022-01-18 | 6 | $75 | $50 | $62.5 | $2.08 | 2904.81% |
| 2022-02-25 | 6 | $77 | $55 | $66.4 | $2.08 | 3092.31% |
| 2022-02-28 | 6 | $77 | $40 | $61 | $2.08 | 2832.69% |
| 2022-03-09 | 6 | $77 | $40 | $60.8 | $2.08 | 2823.08% |
| 2022-04-27 | 6 | $77 | $40 | $60.6 | $2.08 | 2813.46% |
| 2022-05-02 | 6 | $77 | $30 | $56.6 | $2.08 | 2621.15% |
| 2022-05-03 | 6 | $77 | $30 | $50.2 | $2.08 | 2313.46% |
| 2022-05-04 | 6 | $77 | $30 | $48.166 | $2.08 | 2215.67% |
| 2022-05-10 | 5 | $77 | $30 | $48.166 | $2.08 | 2215.67% |
| 2022-06-06 | 4 | $65 | $30 | $44.5 | $2.08 | 2039.42% |
| 2022-08-03 | 5 | $65 | $30 | $43 | $2.08 | 1967.31% |
| 2022-09-13 | 5 | $65 | $29 | $42.833 | $2.08 | 1959.28% |
| 2022-10-26 | 5 | $65 | $29 | $42.666 | $2.08 | 1951.25% |
| 2022-11-09 | 5 | $55 | $25 | $40.333 | $2.08 | 1839.09% |
| 2022-11-11 | 5 | $55 | $23 | $38.166 | $2.08 | 1734.9% |
| 2023-03-02 | 4 | $55 | $15 | $31.2 | $2.08 | 1400% |
| 2023-03-17 | 4 | $55 | $9 | $28.4 | $2.08 | 1265.38% |
| 2023-04-17 | 4 | $38 | $9 | $21.8 | $2.08 | 948.08% |
| 2023-05-11 | 4 | $25 | $9 | $17.75 | $2.08 | 753.37% |
| 2023-05-31 | 3 | $22 | $15 | $17.333 | $2.08 | 733.32% |
| 2023-08-02 | 2 | $22 | $15 | $18.5 | $2.08 | 789.42% |
| 2023-08-10 | 2 | $22 | $11 | $16.5 | $2.08 | 693.27% |
| 2023-11-10 | 2 | $22 | $5 | $13.5 | $2.08 | 549.04% |
The Trend in the Analyst Price Target
Over the past 22 months, EBS's average price target has gone down $49.
Over the past 36 weeks, EBS's average upside potential has been 167.93%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-11 | 4 | 25 | 9 | 17.75 | 10.51 | 68.89% |
| 2023-05-31 | 2 | 22 | 15 | 18.50 | 8.53 | 116.88% |
| 2023-05-31 | 3 | 22 | 15 | 18.50 | 8.53 | 116.88% |
| 2023-08-10 | 2 | 22 | 11 | 16.50 | 5.72 | 188.46% |
| 2023-10-06 | 2 | 22 | 5 | 13.50 | 2.99 | 351.51% |
EBS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.67 | 0 | 0 | 2 | 1 | 1 | 3 |
The Trend in the Broker Recommendations
EBS's average broker recommendation rating improved by 0.5 over the prior 35 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EBS as an investment opportunity.
- In the context of all US stocks, EMERGENT BIOSOLUTIONS INC's upside potential (average analyst target price relative to current price) is greater than 3140.9% of them.
- In terms of how EMERGENT BIOSOLUTIONS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 624.34% of that group.
- In terms of how EMERGENT BIOSOLUTIONS INC fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -2419.74% of that group.
- In terms of how EMERGENT BIOSOLUTIONS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 1901.74% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to EMERGENT BIOSOLUTIONS INC are SUPN, PBH, and FOLD.
View All Top Stocks by Price Target
Is EBS a Buy, Hold or Sell? See the POWR Ratings now!